Medical Loss Ratio rule symbolic at best, sure to drive out innovation
PPACA's provisions make grim assumptions about the market and its ability to self-correct


No one who understands this business believes a health insurance company should deliver only 65 or 70 cents worth of care for every dollar collected. But the architects of the Patient Protection and Affordable Care Act (PPACA) can point to moments over the past decades when the medical loss ratios (MLRs) of some profitable insurers dipped that low. The market took two enrollment periods to correct, and many of those same plans were underwater three years later.

The MLR itself naturally becomes the accounting target for everyone who believes that health insurers are denying people not just reimbursement, but treatment, life and hope. Had PPACA's 80% and 85% MLR rule been applied to 2010, insurers would have refunded approximately $2 billion collectively. The rule essentially assumes that:

Health insurance markets do not work;

Most of these "markets" are controlled by cabals of large, price-fixing insurers;

Employers are dupes who cannot price discriminate, nor negotiate, and are simply happy to pass along excessive premiums to employees;

Agents and brokers actually benefit from prices kept artificially high by this market failure; and

Health insurers can and will gouge customers and get away with it forever.

The overarching goal of PPACA is to flatten and broaden coverage, reallocating funds from the insured to the uninsured, based on the hard reality that this reallocation occurs anyway, through the grossly inefficient mechanisms of provider mark-ups and cross-subsidies. Because the MLR calculations govern the largest countable pots of money in the healthcare system, they seem like an obvious tool for re-engineering—especially given how politically easy it is to go after "excessive" insurer profits.

In reality, the $2 billion refund would amount to less than one-quarter of 1% of what all enrollees spent on health insurance in 2010. So how will the imposition of the MLR refund rule radically reshape the pricing and distribution of health insurance—soon to be a $1 trillion marketplace or 500 times the size of that 2010 refund?

The industry—which engaged in much of the PPACA debate in good faith—is understandably hyperventilating about the effects of a rule loaded with populist symbolism, if not actual financial firepower. They react to what is yet another cumbersome and barely material compliance ritual—one fraught with huge public-relations risks.

In terms of innovation for the industry, consider where almost all the venture capital in healthcare has fled: consumer health, provider IT, health 2.0, and provider consolidation, with almost nothing going toward new and better forms of health insurance. Much of this venture capital originates with the large insurers themselves, in a desperate search for revenue diversification ahead of PPACA and MLR deadlines.

Forget about the emergence of bold new players who can significantly change the health insurance game. The MLR rule is a profit-regulation mechanism, plain and simple. Like all other forms of price controls, this one will drive away innovators and capital and send all of today's players into a dogfight for total profit growth (versus profit margin growth) through consolidation.

If the federal government wants to convert health insurers into profit-regulated public utilities—with a capital base and innovation culture to match—that may be precisely what it gets.

J.D. Kleinke is a medical economist, author and MHE editorial advisor. He was appointed a resident Fellow at the American Enterprise Institute earlier this month.


Also Visit
AEIdeas Blog The American Magazine
About the Author



What's new on AEI

Love people, not pleasure
image Oval Office lacks resolve on Ukraine
image Middle East Morass: A public opinion rundown of Iraq, Iran, and more
image Verizon's Inspire Her Mind ad and the facts they didn't tell you
AEI on Facebook
Events Calendar
  • 21
  • 22
  • 23
  • 24
  • 25
Monday, July 21, 2014 | 9:15 a.m. – 11:30 a.m.
Closing the gaps in health outcomes: Alternative paths forward

Please join us for a broader exploration of targeted interventions that provide real promise for reducing health disparities, limiting or delaying the onset of chronic health conditions, and improving the performance of the US health care system.

Monday, July 21, 2014 | 4:00 p.m. – 5:30 p.m.
Comprehending comprehensive universities

Join us for a panel discussion that seeks to comprehend the comprehensives and to determine the role these schools play in the nation’s college completion agenda.

Tuesday, July 22, 2014 | 8:50 a.m. – 12:00 p.m.
Who governs the Internet? A conversation on securing the multistakeholder process

Please join AEI’s Center for Internet, Communications, and Technology Policy for a conference to address key steps we can take, as members of the global community, to maintain a free Internet.

Event Registration is Closed
Thursday, July 24, 2014 | 9:00 a.m. – 10:00 a.m.
Expanding opportunity in America: A conversation with House Budget Committee Chairman Paul Ryan

Please join us as House Budget Committee Chairman Paul Ryan (R-WI) unveils a new set of policy reforms aimed at reducing poverty and increasing upward mobility throughout America.

Thursday, July 24, 2014 | 6:00 p.m. – 7:15 p.m.
Is it time to end the Export-Import Bank?

We welcome you to join us at AEI as POLITICO’s Ben White moderates a lively debate between Tim Carney, one of the bank’s fiercest critics, and Tony Fratto, one of the agency’s staunchest defenders.

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.